Max Richly, PhD, is currently a Deep Tech Consultant at the Boston Consulting Group (BCG). They previously co-founded and served as CEO of LumediX, focusing on enhancing In Vitro Diagnostics through innovative nanoparticles. Max's extensive academic background includes a PhD in Biophysics from Ecole Polytechnique and participation in the Stanford Ignite program for Global Innovation and Entrepreneurship. Earlier in their career, they led projects at Ecole Polytechnique involving advanced protein detection technologies and completed a research internship at the Max Planck Institute for Plasma Physics.
Location
Paris, France
This person is not in the org chart
This person is not in any teams
This person is not in any offices